| Q36587768 | Activated NF-κB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling. |
| Q36733053 | Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts |
| Q38818913 | Age-dependent alterations in osteoblast and osteoclast activity in human cancellous bone |
| Q54684809 | Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1. |
| Q26774874 | Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review |
| Q43252993 | Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation |
| Q36702302 | Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C |
| Q36532536 | Bone cell precursors and the pathophysiology of bone loss |
| Q34001621 | Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention |
| Q33896725 | Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment |
| Q58774487 | Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications |
| Q38598776 | Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission? |
| Q35769060 | Cells of the synovium in rheumatoid arthritis. Osteoclasts |
| Q35901092 | Clinical development of anti-RANKL therapy |
| Q34252489 | Cytokine-mediated bone destruction in rheumatoid arthritis |
| Q26782454 | Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus |
| Q28303865 | Cytokines in the pathogenesis of rheumatoid arthritis |
| Q37342578 | Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT. |
| Q28295303 | Disorders of Bone Remodeling |
| Q53742233 | Editorial: Inflammatory Osteoclasts: A Different Breed of Bone Eaters? |
| Q37880163 | Effects of inflammatory and anti-inflammatory cytokines on the bone |
| Q35901078 | Erosive arthritis |
| Q26863571 | Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8 |
| Q38295616 | Focal bone involvement in inflammatory arthritis: the role of IL17. |
| Q35075554 | Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation |
| Q43190058 | How does joint remodeling work?: new insights in the molecular regulation of the architecture of joints |
| Q36394731 | Human scaphoid non-unions exhibit increased osteoclast activity compared to adjacent cancellous bone |
| Q40909592 | IL-1 mediates TNF-induced osteoclastogenesis |
| Q34545945 | IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells |
| Q64118198 | Imaging the Bone-Immune Cell Interaction in Bone Destruction |
| Q38114066 | Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo |
| Q35913720 | Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin |
| Q38618883 | Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review |
| Q91925637 | Inflammatory processes and elevated osteoclast activity chaperon atrophic non-union establishment in a murine model |
| Q37829690 | Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications |
| Q35011305 | Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process |
| Q35775909 | Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-1β-induced arthritis |
| Q53221110 | Lineage-committed osteoclast precursors circulate in blood and settle down into bone. |
| Q37143025 | Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. |
| Q36618009 | Mechanisms of bone loss in rheumatoid arthritis |
| Q34246045 | Mice Deficient in NF-κB p50 and p52 or RANK Have Defective Growth Plate Formation and Post-natal Dwarfism. |
| Q38721980 | Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy. |
| Q35939914 | Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis. |
| Q34488033 | Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice |
| Q37363042 | NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism |
| Q64235920 | New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis |
| Q36246080 | OsteoRheumatology: a new discipline? |
| Q28593804 | Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha |
| Q36568536 | Osteoclast fusion and regulation by RANKL-dependent and independent factors |
| Q79370827 | Osteoclastic differentiation and function regulated by old and new pathways |
| Q35755039 | Osteoclasts: New Insights |
| Q38109578 | Osteoimmunology and bone homeostasis: relevance to spondyloarthritis |
| Q37626412 | Osteoimmunology and the effects of the immune system on bone |
| Q47944184 | Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. |
| Q37544448 | Osteoimmunology: crosstalk between the immune and bone systems |
| Q24655113 | Osteoimmunology: interactions of the bone and immune system |
| Q28294477 | Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems |
| Q64071144 | Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli |
| Q45091256 | PC-PLC is involved in osteoclastogenesis induced by TNF-α through upregulating IP3R1 expression |
| Q36090203 | Pathological role of osteoclast costimulation in arthritis-induced bone loss. |
| Q37115802 | Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis |
| Q51426261 | RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro. |
| Q37738754 | RANK ligand: effects of inhibition. |
| Q46515547 | RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis |
| Q34333628 | Receptor Activator of NF-κB (RANK) Cytoplasmic IVVY535–538 Motif Plays an Essential Role in Tumor Necrosis Factor-α (TNF)-mediated Osteoclastogenesis |
| Q36860987 | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. |
| Q33946711 | Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation |
| Q38102876 | Regulation of TNF-α with a focus on rheumatoid arthritis |
| Q37118782 | Review: Immune cells and mediators of inflammatory arthritis |
| Q38215027 | Role of periodontal ligament fibroblasts in osteoclastogenesis: a review |
| Q36177501 | Roles for NF-kappaB and c-Fos in osteoclasts |
| Q37670112 | Runx1-mediated regulation of osteoclast differentiation and function |
| Q40463168 | Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis. |
| Q34950018 | Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats |
| Q50523565 | Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis. |
| Q37801555 | Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis |
| Q93053015 | TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis |
| Q35760837 | TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. |
| Q48088552 | TNF-α promotes osteoclastogenesis through JNK signaling-dependent induction of Semaphorin3D expression in estrogen-deficiency induced osteoporosis. |
| Q52784518 | Targeting Notch-Activated M1 Macrophages Attenuates Joint Tissue Damage in a Mouse Model of Inflammatory Arthritis. |
| Q36093022 | The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis |
| Q43494262 | The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis |
| Q41973199 | The role of bone marrow edema and lymphangiogenesis in inflammatory-erosive arthritis |
| Q39248512 | The role of stromal cells in inflammatory bone loss |
| Q48867598 | The sphingosine-1-phosphate receptor 1 binding molecule FTY720 inhibits osteoclast formation in rats with ligature-induced periodontitis |
| Q33360030 | The synovio-entheseal complex in enthesoarthritis |
| Q54460498 | Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis. |
| Q36901702 | Use of a whole-slide imaging system to assess the presence and alteration of lymphatic vessels in joint sections of arthritic mice |
| Q39982542 | Value of digital X-ray radiogrammetry in the assessment of inflammatory bone loss in rheumatoid arthritis |
| Q93052617 | Vitamin D Inhibition of TRPV5 Expression During Osteoclast Differentiation |
| Q80463776 | [Bone metabolism: molecular mechanisms] |
| Q44536102 | p-Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model. |